-
Start Preamble
Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 15, 2000, Radian International LLC, 14050 Summit Drive #121, P.O. Box 201088, Austin, Texas 78720-1088, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:
Drug Schedule Gamma hydroxybutyric acid (2010) I Thebaine (9333) II The firm plans to manufacture small quantities of the listed controlled substances to make deuterated and non-deuterated drug reference standards which will be distributed to analytical and forensic laboratories for drug testing programs.
Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Start Printed Page 51332Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than October 23, 2000.
Start SignatureDated: August 8, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 00-21486 Filed 8-22-00; 8:45 am]
BILLING CODE 4410-09-M
Document Information
- Published:
- 08/23/2000
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- 00-21486
- Pages:
- 51331-51332 (2 pages)
- PDF File:
- 00-21486.pdf